Isolated tricuspid valve regurgitation: old concepts, new insights and innovation.
Cardiac Catheterization
/ adverse effects
Cardiac Valve Annuloplasty
/ adverse effects
Diuretics
Heart Valve Prosthesis
Heart Valve Prosthesis Implantation
/ adverse effects
Hemodynamics
Humans
Recovery of Function
Risk Factors
Treatment Outcome
Tricuspid Valve
/ diagnostic imaging
Tricuspid Valve Insufficiency
/ diagnostic imaging
Journal
Journal of cardiovascular medicine (Hagerstown, Md.)
ISSN: 1558-2035
Titre abrégé: J Cardiovasc Med (Hagerstown)
Pays: United States
ID NLM: 101259752
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
pubmed:
20
2
2020
medline:
20
1
2021
entrez:
20
2
2020
Statut:
ppublish
Résumé
: Tricuspid valve regurgitation is usually progressive and associated with reduced long-term survival. International guidelines recommend surgery in cases of isolated severe regurgitation associated with symptoms or progressive worsening of right ventricular function. In addition, several percutaneous strategies have been reported with promising results in the last decade. The aim of the present review is to summarize the current state of the art in the management of isolated functional or degenerative tricuspid valve insufficiency, from the preoperative assessment to the results of both surgical and transcatheter approaches and explore future directions.
Identifiants
pubmed: 32073432
doi: 10.2459/JCM.0000000000000933
pii: 01244665-202006000-00002
doi:
Substances chimiques
Diuretics
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
406-414Références
Bar N, Schwartz LA, Biner S, et al. Clinical outcome of isolated tricuspid regurgitation in patients with preserved left ventricular ejection fraction and pulmonary hypertension. J Am Soc Echocardiogr 2018; 31:34–41.
Asmarats L, Puri R, Latib A, Navia JL, Rodes-Cabau J. Transcatheter tricuspid valve interventions: landscape, challenges, and future directions. J Am Coll Cardiol 2018; 71:2935–2956.
Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol 2004; 43:405–409.
Wang N, Fulcher J, Abeysuriya N, et al. Tricuspid regurgitation is associated with increased mortality independent of pulmonary pressures and right heart failure: a systematic review and meta-analysis. Eur Heart J 2019; 40:476–484.
Taramasso M, Gavazzoni M, Maisano F. Is tricuspid regurgitation a prognostic interventional target or is it just an indicator of worst prognosis in heart failure patients? Eur Heart J 2019; 40:485–487.
Stuge O, Liddicoat J. Emerging opportunities for cardiac surgeons within structural heart disease. J Thorac Cardiovasc Surg 2006; 132:1258–1261.
Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2017; 38:2739–2791.
Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2017; 70:252–289.
Latib A, Grigioni F, Hahn RT. Tricuspid regurgitation: what is the real clinical impact and how often should it be treated? EuroIntervention: journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2018; 14:AB101–AB111.
Zoghbi WA, Adams D, Bonow RO, et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr 2017; 30:303–371.
Hahn RT, Zamorano JL. The need for a new tricuspid regurgitation grading scheme. Eur Heart J Cardiovasc Imaging 2017; 18:1342–1343.
Bartko PE, Arfsten H, Frey MK, et al. Natural history of functional tricuspid regurgitation: implications of quantitative doppler assessment. JACC Cardiovasc Imaging 2019; 12:389–397.
Rodes-Cabau J, Taramasso M, O’Gara PT. Diagnosis and treatment of tricuspid valve disease: current and future perspectives. Lancet 2016; 388:2431–2442.
Zack CJ, Fender EA, Chandrashekar P, et al. National trends and outcomes in isolated tricuspid valve surgery. J Am Coll Cardiol 2017; 70:2953–2960.
Alqahtani F, Berzingi CO, Aljohani S, Hijazi M, Al-Hallak A, Alkhouli M. Contemporary trends in the use and outcomes of surgical treatment of tricuspid regurgitation. J Am Heart Assoc 2017; 6: pii: e007597.
pii: e007597
Axtell AL, Bhambhani V, Moonsamy P, et al. Surgery does not improve survival in patients with isolated severe tricuspid regurgitation. J Am Coll Cardiol 2019; 13:715–725.
Schneider M, Ran H, Aschauer S, et al. Visual assessment of right ventricular function by echocardiography: how good are we? Int J Cardiovasc Imaging 2019; 35:2001–2008.
Saran N, Dearani JA, Said SM, et al. Long-term outcomes of patients undergoing tricuspid valve surgerydagger. Eur J Cardiothorac Surg 2019; 56:950–958.
Russo M, Kuwata S, Pozzoli A, Maisano F, Taramasso M. Understanding the tricuspid valve for transcatheter valve repair: comparative anatomy of different imaging modalities. Eur Heart J Cardiovasc Imaging 2017; 18:823.
Nickenig G, Kowalski M, Hausleiter J, et al. Transcatheter treatment of severe tricuspid regurgitation with the edge-to-edge MitraClip technique. Circulation 2017; 135:1802–1814.
Pozzoli A, Maisano F, Kuwata S, et al. Fluoroscopic anatomy of the tricuspid valve: implications for transcatheter procedures. Int J Cardiol 2017; 244:119–120.
Taramasso M, Hahn RT, Alessandrini H, et al. The International Multicenter TriValve Registry: which patients are undergoing transcatheter tricuspid repair? JACC Cardiovasc Interv 2017; 10:1982–1990.
Taramasso M, Alessandrini H, Latib A, et al. Outcomes after current transcatheter tricuspid valve intervention: mid-term results from the International TriValve Registry. JACC Cardiovasc Interv 2019; 12:155–165.
Andreas M, Russo M, Taramasso M, Zuber M, Mascherbauer J. Novel transcatheter clip device (MitraClip XTR) enables significant tricuspid annular size reduction. Eur Heart J Cardiovasc Imaging 2019; 20:1070.
Nakanishi K, Homma S, Han J, et al. Prevalence, predictors, and prognostic value of residual tricuspid regurgitation in patients with left ventricular assist device. J Am Heart Assoc 2018; 7:e008813.
Kolsrud O, Karason K, Holmberg E, et al. Renal function and outcome after heart transplantation. J Thorac Cardiovasc Surg 2018; 155:1593.e1–604.e1.
Ailawadi G, Lapar DJ, Swenson BR, et al. Model for end-stage liver disease predicts mortality for tricuspid valve surgery. Ann Thorac Surg 2009; 87:1460–1467.
Ben-Dor I, Gaglia MA Jr, Barbash IM, et al. Comparison between Society of Thoracic Surgeons score and logistic EuroSCORE for predicting mortality in patients referred for transcatheter aortic valve implantation. Cardiovasc Revasc Med 2011; 12:345–349.
Wendt D, Thielmann M, Kahlert P, et al. Comparison between different risk scoring algorithms on isolated conventional or transcatheter aortic valve replacement. Ann Thorac Surg 2014; 97:796–802.
Godino C, Scotti A, Munafo A, et al. Observed versus predicted mortality after MitraClip treatment in patients with symptomatic heart failure and significant functional mitral regurgitation. Eur J Heart Fail 2018; 20:1495–1496.
LaPar DJ, Likosky DS, Zhang M, et al. Investigators for the Virginia Cardiac Surgery Quality Initiative and the Michigan Society of Thoracic and Cardiovascular Surgeons. Development of a risk prediction model and clinical risk score for isolated tricuspid valve surgery. Ann Thorac Surg 2018; 106:129–136.
Veen KM, Muslem R, Soliman OI, et al. Left ventricular assist device implantation with and without concomitant tricuspid valve surgery: a systematic review and meta-analysis. Eur J Cardiothorac Surg 2018; 54:644–651.
Hamandi M, Smith RL, Ryan WH, et al. Outcomes of isolated tricuspid valve surgery have improved in the modern era. Ann Thorac Surg 2019; 108:11–15.
Ejiofor JI, Neely RC, Yammine M, et al. Surgical outcomes of isolated tricuspid valve procedures: repair versus replacement. Ann Cardiothorac Surg 2017; 6:214–222.
Mehr M, Taramasso M, Besler C, et al. 1-Year outcomes after edge-to-edge valve repair for symptomatic tricuspid regurgitation: results from the TriValve Registry. JACC Cardiovasc Interv 2019; 12:1451–1461.
Besler C, Orban M, Rommel KP, et al. Predictors of procedural and clinical outcomes in patients with symptomatic tricuspid regurgitation undergoing transcatheter edge-to-edge repair. JACC Cardiovasc Interv 2018; 11:1119–1128.
Nashef SA, Roques F, Sharples LD, et al. EuroSCORE II. Eur J Cardio-thorac Surg 2012; 41:734–744. discussion 44-45.
O’Brien SM, Shahian DM, Filardo G, et al. Society of Thoracic Surgeons Quality Measurement Task Force. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery. Ann Thorac Surg 2009; 88: (1 Suppl): S23–S42.
Shahian DM, Blackstone EH, Edwards FH, et al. Cardiac surgery risk models: a position article. Ann Thorac Surg 2004; 78:1868–1877.
Hahn RT1, Meduri CU2, Davidson CJ, et al. Early feasibility study of a transcatheter tricuspid valve annuloplasty: SCOUT trial 30-day results. J Am Coll Cardiol 2017; 69:1795–1806.
Nickenig G, Weber M, Schueler R, et al. 6-month outcomes of tricuspid valve reconstruction for patients with severe tricuspid regurgitation. J Am Coll Cardiol 2019; 73:1905–1915.
Vassileva CM, Shabosky J, Boley T, Markwell S, Hazelrigg S. Tricuspid valve surgery: the past 10 years from the Nationwide Inpatient Sample (NIS) database. J Thorac Cardiovasc Surg 2012; 143:1043–1049.
Garbade J, Gustafsson F, Shaw S, et al. Postmarket experience with HeartMate 3 left ventricular assist device: 30-day outcomes from the ELEVATE Registry. Ann Thorac Surg 2018; 107:33–39.
Gustafsson F, Shaw S, Lavee J, et al. Six-month outcomes after treatment of advanced heart failure with a full magnetically levitated continuous flow left ventricular assist device: report from the ELEVATE registry. Eur Heart J 2018; 39:3454–3460.
Bellavia D, Iacovoni A, Scardulla C, et al. Prediction of right ventricular failure after ventricular assist device implant: systematic review and meta-analysis of observational studies. Eur J Heart Fail 2017; 19:926–946.
Boegershausen N, Zayat R, Aljalloud A, et al. Risk factors for the development of right ventricular failure after left ventricular assist device implantation-a single-centre retrospective with focus on deformation imaging. Eur J Cardiothorac Surg 2017; 52:1069–1076.
Piacentino V 3rd, Williams ML, Depp T, et al. Impact of tricuspid valve regurgitation in patients treated with implantable left ventricular assist devices. Ann Thorac Surg 2011; 91:1342–1346.
Luscher TF. Valvular heart disease: tricuspid regurgitation is the new frontier. Eur Heart J 2018; 39:3555–3557.
Feldman D, Pamboukian SV, Teuteberg JJ, et al. International Society for Heart and Lung Transplantation. The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant 2013; 32:157–187.
Veen KM, Caliskan K, de By T, et al. Outcomes after tricuspid valve surgery concomitant with left ventricular assist device implantation in the EUROMACS registry: a propensity score matched analysis. Eur J Cardiothorac Surg 2019; 56:1081–1089.
Hausleiter J, Braun D, Orban M, et al. Patient selection, echocardiographic screening and treatment strategies for interventional tricuspid repair using the edge-to-edge repair technique. EuroIntervention 2018; 14:645–653.
Rommel KP, Besler C, Noack T, et al. Physiological and clinical consequences of right ventricular volume overload reduction after transcatheter treatment for tricuspid regurgitation. JACC Cardiovasc Interv 2019; 12:1423–1434.